These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 11875412)

  • 1. Real options for biotechnology valuation.
    Harrison M; Lerer L
    Nat Biotechnol; 2002 Mar; 20(3):223-4. PubMed ID: 11875412
    [No Abstract]   [Full Text] [Related]  

  • 2. Kiran Mazumdar-Shaw.
    Jayaraman KS
    Nat Biotechnol; 2005 Jan; 23(1):11. PubMed ID: 15637602
    [No Abstract]   [Full Text] [Related]  

  • 3. Finnish biotechnology--built on solid foundations.
    Lähteenmäki R
    Nature; 2002 Dec; 420(6916 Suppl):A34-5, A37, A39. PubMed ID: 12501125
    [No Abstract]   [Full Text] [Related]  

  • 4. On the road to California.
    DeWitt N
    Nature; 2002 Dec; 420(6916 Suppl):A9. PubMed ID: 12510695
    [No Abstract]   [Full Text] [Related]  

  • 5. Putting a price on biotechnology.
    Stewart JJ; Allison PN; Johnson RS
    Nat Biotechnol; 2001 Sep; 19(9):813-7. PubMed ID: 11533634
    [No Abstract]   [Full Text] [Related]  

  • 6. NASD rule requires disclosure.
    Bouchie A
    Nat Biotechnol; 2001 Aug; 19(8):705. PubMed ID: 11491105
    [No Abstract]   [Full Text] [Related]  

  • 7. France boosts funding for biotechnology start-ups.
    Goodman S
    Nature; 2001 Dec; 414(6864):573. PubMed ID: 11740520
    [No Abstract]   [Full Text] [Related]  

  • 8. Valuing biotechnology assets.
    Nelson TR; Mukherji A
    Nat Biotechnol; 1998 Jun; 16(6):525-9. PubMed ID: 9624681
    [No Abstract]   [Full Text] [Related]  

  • 9. Aligning interests.
    Nat Biotechnol; 2008 Nov; 26(11):1199. PubMed ID: 18997739
    [No Abstract]   [Full Text] [Related]  

  • 10. Investors bullish in Q1.
    Lawrence S
    Nat Biotechnol; 2006 May; 24(5):486. PubMed ID: 16680118
    [No Abstract]   [Full Text] [Related]  

  • 11. Biotechnology. Stem cells lose market luster.
    Vogel G
    Science; 2003 Mar; 299(5614):1830-1. PubMed ID: 12649456
    [No Abstract]   [Full Text] [Related]  

  • 12. Finnish biotechnology--built on solid foundations.
    Lähteenmäki R
    Nat Biotechnol; 2002 May; 20(5):437-40. PubMed ID: 11981550
    [No Abstract]   [Full Text] [Related]  

  • 13. Biotechnology unscathed in Korean finance crisis?
    Saegusa A
    Nat Biotechnol; 1998 Feb; 16(2):151. PubMed ID: 9487520
    [No Abstract]   [Full Text] [Related]  

  • 14. Fragmentation is industry obstacle in Europe.
    Mitchell P
    Nat Biotechnol; 2001 Jun; 19(6):494-5. PubMed ID: 11385414
    [No Abstract]   [Full Text] [Related]  

  • 15. The number on biotech indexes.
    Jacobs T
    Nat Biotechnol; 2005 Nov; 23(11):1356. PubMed ID: 16273059
    [No Abstract]   [Full Text] [Related]  

  • 16. Kick-starting biotechnology in Ontario.
    Endersby JM
    Nat Biotechnol; 1999 May; 17(5):444-6. PubMed ID: 10331800
    [No Abstract]   [Full Text] [Related]  

  • 17. State of the biotech sector - 2006.
    Lawrence S
    Nat Biotechnol; 2007 Jul; 25(7):706. PubMed ID: 17621283
    [No Abstract]   [Full Text] [Related]  

  • 18. What a stock analyst can do for you.
    Jacobs T
    Nat Biotechnol; 2005 Sep; 23(9):1063. PubMed ID: 16151392
    [No Abstract]   [Full Text] [Related]  

  • 19. Share slump brings biotech firms to government's door.
    Check E
    Nature; 2003 Jun; 423(6943):908. PubMed ID: 12827159
    [No Abstract]   [Full Text] [Related]  

  • 20. France critiques its incubator before refinancing.
    Louët S
    Nat Biotechnol; 2004 Jan; 22(1):126. PubMed ID: 14725299
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.